Riskpilot← Back to searchSign inGet full accessMEDICURA AS
ASActiveOrg 927088908Enebakkveien 150, 0680 OsloMedical specialists activities · NACE 8622Est. 20212 employees
Revenue 2024
NOK 6,5M
+2% vs 2023
EBITDA margin
-1.3%
-112% vs 2023
Equity ratio
7.7%
Financial strength
Net profit 2024
NOK -194K
-133% vs 2023
| Revenue | NOK 6,5M | +2% |
| EBITDA | NOK -88K | -112% |
| Net profit | NOK -194K | -133% |
| Total assets | NOK 962K | +13% |
| Equity | NOK 74K | -37% |
| Employees | 2 | — |
Legal name
MEDICURA AS
Org number
927088908
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
8. mai 2021
Share capital
NOK 105 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Selge tjenester og varer innen medisinske tjenester og annet som naturlig sammenfaller med dette, samt deltakelse i andre selskaper, investeringer og nærliggende virksomhet.
Address
Enebakkveien 150, 0680 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 788 | 4 278 | 6 415 | 6 542 |
| Staff expenses | −0 | −522 | −1 374 | −2 096 |
| EBITDA | −447 | −19 | 709 | −88 |
| Depreciation & amort. | −8 | −21 | −31 | −82 |
| EBIT | −456 | −41 | 678 | −169 |
| Net financials | −0 | −3 | −38 | −25 |
| Profit before tax | −456 | −43 | 640 | −194 |
| Tax | −0 | −0 | 53 | −0 |
| Net profit | −456 | −43 | 587 | −194 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 230 | 1 036 | 853 | 962 |
| Equity | −426 | −469 | 118 | 74 |
| Long-term debt | 0 | 0 | 0 | 266 |
| Short-term debt | 655 | 1 505 | 734 | 622 |
| Total debt | 655 | 1 505 | 734 | 888 |
EBITDA margin
-1.3%
This company
15.8%
Market median
-108% vs market
20212024
Equity ratio
7.7%
This company
38.2%
Market median
-80% vs market
20212024
Return on equity
-262.1%
This company
18.4%
Market median
-1524% vs market
20212024
Net profit margin
-3.0%
This company
8.1%
Market median
-137% vs market
20212024
Asset turnover
6.80×
This company
1.12×
Market median
+507% vs market
20212024
Debt / equity
11.98×
This company
0.62×
Market median
-1832% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TR Chief Executive Officer | Chief Executive Officer | 2026 |
GO Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Idekompaniet As
MEDICURA AS Board members of MEDICURA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Roger Viken | Chief Executive Officer | 0 companies |
| Geir Ove Hauge | Chief Executive Officer | 0 companies |
| Christian Amundsen | Chairman | 0 companies |